Strategic Growth Terumo's acquisition of OrganOx expands its organ preservation portfolio, creating cross-sell opportunities with cardiovascular and embolization lines for transplant centers and large health systems. Leverage this expanded portfolio to offer integrated procurement solutions and bundled services.

Safety Innovation SurTract Safety Syringe launch highlights a safety-first sales proposition; target hospital procurement and anesthesia/cath lab programs with a bundled offering including safety syringes and staff training via ComplianceWire.

Regional Manufacturing Advantage Puerto Rico facility expansion improves near-term US supply resilience and lead times; use as a selling point for hospital networks seeking reliable, localized manufacturing for vascular and embolization devices.

Vascular Focus AZUR HydroPack Peripheral Coil System and related vascular plugs indicate a growing embolotherapy portfolio; target interventional radiology centers, vascular surgery programs, and ASC networks; propose bundled device kits and training to drive adoption.

Scale and Partnerships Terumo's market position and recent acquisitions suggest capacity to support long-term procurements; approach GPOs and large hospital systems for multi-year contracts and standardization; leverage existing distributor partnerships to accelerate market access.